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rotein translocons of the mammalian endoplasmic
reticulum are composed of numerous functional
components whose organization during different stages
of the transport cycle in vivo remains poorly understood. We
have developed generally applicable methods based on
ﬂuorescence resonance energy transfer (FRET) to probe the
relative proximities of endogenously expressed translocon
components in cells. Examination of substrate-engaged
translocons revealed oligomeric assemblies of the Sec61
complex that were associated to varying degrees with other
P
 
essential components including the signal recognition
particle receptor TRAM and the TRAP complex. Remarkably,
these components not only remained assembled but also
had a similar, yet distinguishable, organization both during
and after nascent chain translocation. The persistence of
preassembled and complete translocons between successive
rounds of transport may facilitate highly efﬁcient translocation
in vivo despite temporal constraints imposed by ongoing
translation and a crowded cellular environment.
 
Introduction
 
The biogenesis of secretory and membrane proteins in
mammalian cells involves several discrete steps that include
targeting of nascent polypeptides to the ER, their cotransla-
tional transport across or integration into the ER membrane,
and various modification, folding, and maturation events
(for review see Rapoport et al., 1996; Johnson and van
Waes, 1999). The ability to reconstitute this entire process
in a cell-free system amenable to biochemical fractionation
has allowed each stage to be studied in isolation and has
facilitated the identification of the respective factors involved.
Collectively, the multiple components that define the
machinery for cotranslational protein translocation constitute
the translocon.
Central among the translocon components is the hetero-
trimeric Sec61 complex (composed of 
 
 
 
, 
 
 
 
, and 
 
 
 
 subunits),
multiple copies of which are thought to be assembled to
form the core of a protein-conducting translocation channel
(Hanein et al., 1996; Beckmann et al., 1997, 2001; Menetret
et al., 2000; Morgan et al., 2002). Signal sequence–containing
nascent polypeptides, recognized first by the cytoplasmic
signal recognition particle (SRP), are targeted to the Sec61
channel by another translocon component, the heterodimeric
SRP receptor (SR; for review see Rapoport et al., 1996).
Although some nascent chains can subsequently insert directly
into the Sec61 channel (Jungnickel and Rapoport, 1995),
most substrates require the aid of at least one of two addi-
tional translocon components, the TRAM protein (Gorlich
and Rapoport, 1993; Voigt et al., 1996) and/or the heterotet-
rameric TRAP complex (Fons et al., 2003). Once these critical
first steps result in a commitment to initiate substrate trans-
location, other translocon components can interact with the
nascent chain during its transport to catalyze reactions such as
signal sequence cleavage and glycosylation. Thus, a biochemical
approach has provided the general framework for ordering a
succession of individual steps whose mechanistic basis can be
further dissected.
In spite of this level of mechanistic insight, basic aspects of
translocon composition and organization during its functional
cycle in vivo remain poorly or not at all understood. One of
the most elemental yet unresolved issues in this regard is the
fate of a translocon, and in particular the translocation
channel, between rounds of substrate transport. The first of
two general possibilities is that the constituents of the
channel, whose assembly would be directed by a nascent
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substrate, are disassembled upon completion of transport.
Alternatively, the channel may remain assembled when not
in use and closed on one or both ends to prevent compro-
mising the permeability barrier of the ER.
The currently available data from biochemical studies
have yielded evidence for both situations. Despite the lack of
copurification of various components of the translocon, they
can nonetheless be core-constituted into proteoliposomes
that support functional protein transport (Gorlich and Rap-
oport, 1993). In addition, purified Sec61 complex incorpo-
rated into lipid vesicles was not observed to oligomerize into
channel-like structures until the addition of ribosomes (Ha-
nein et al., 1996). Both of these observations show that
translocation channels can be assembled de novo from their
isolated constituents, lending credence to a model involving
use-dependent assembly and disassembly of the translocon.
In contrast, vacating the translocation channel of its na-
scent chain in vitro with puromycin did not result in a gross
structural change or a reduction in the number of translo-
cons that were observed by freeze-fracture EM (Hanein et
al., 1996). In addition, puromycin was observed to stimu-
late the flux of both ions (Simon and Blobel, 1991) and a
noncharged small molecule (Roy and Wonderlin, 2003)
through channels that had presumably been occluded by
translocating substrates. Thus, translocons may not disas-
semble or even close upon completion of substrate transport.
However, it is presumed that a pore large enough to trans-
port a protein could not remain open while not in use because
the permeability barrier of the ER would be compromised
(Crowley et al., 1994). Indeed, ER-derived microsomal vesi-
cles after removal of their lumenal contents with alkaline ex-
traction were permeable to ions through channels that could
be sterically blocked with either ribosomes or antibodies
against Sec61
 
 
 
 or TRAM (Hamman et al., 1998). These
channels, speculated to reflect the configuration of translo-
cons between rounds of translocation, were not only smaller
than an active translocon (pore size of 
 
 
 
0.9–1.7 nm vs. 
 
 
 
4–
6 nm) but also capable of being sealed to ions by the ER lu-
menal chaperone BiP (Hamman et al., 1998). These observa-
tions suggest a model in which completion of translocation
results in a substantial change in the organization of translo-
cons that remain assembled between rounds of transport.
However, such large changes in pore size have yet to be ob-
served in cryo-EM images (at 
 
 
 
1.5–2 nm resolution) com-
paring translocons assembled onto either empty or nascent
chain–containing ribosomes (Menetret et al., 2000; Beck-
mann et al., 2001). Recently, an X-ray structure of the ar-
chaeal Sec61 homologue (termed SecYE
 
 
 
) suggested a revers-
ibly occludable pore within a single heterotrimer (Van den
Berg et al., 2004), raising the possibility that the functional
state of a translocon may change without necessarily requiring
changes in the overall assembly or organization of translocon
components. Thus, the nature of organizational changes
during the transport cycle of the core Sec61 translocation
channel remains uncertain, with different conclusions being
reached with different methods.
Although considerable functional data are available for SR
and to a lesser extent TRAM and the TRAP complex, little
is known regarding the contributions of these components
to either the composition or the architecture of a native
translocon. The functional activities of each protein appear
to be required at specified times during substrate transloca-
tion. Whether or not these proteins are stably assembled
into native translocons or recruited transiently in a use-depen-
dent manner is not known. Analysis by blue native
PAGE did not reveal clear evidence for oligomeric com-
plexes containing any two of the essential translocon compo-
nents Sec61, SR, TRAM, or TRAP (Wang and Dobber-
stein, 1999). Similarly, no two of these components have
been observed to copurify in studies of their functional puri-
fication and reconstitution (Gorlich et al., 1992; Gorlich
and Rapoport, 1993; Fons et al., 2003). Thus, biochemical
analyses to this point have failed to clearly reveal stable inter-
actions between various translocon components that must
nonetheless be near each other, at least transiently, during
specific stages of translocation.
Together, these various observations show that not only is
the issue of translocation channel assembly and disassembly
uncertain but also the nature of different structural states rep-
resenting active and inactive translocons remains obscure. To
begin addressing these unanswered questions regarding trans-
locon organization, we have developed a method based on
fluorescence resonance energy transfer (FRET) to probe the
relative proximities of endogenously expressed translocon
components in cells at low nanometer resolution. This ap-
proach was subsequently exploited to provide new insights
into both the composition and organizational state of the
translocon during its functional cycle in cells.
 
Results
 
Experimental rationale and strategy
 
An investigation of translocon composition and organiza-
tion in cells requires methodology capable of providing in-
formation on the relative proximities of the constituent pro-
teins at low nanometer resolution. With such a tool, an
analysis of the positions of different combinations of translo-
con components can be used to infer their direct associa-
tions, and hence general features of their overall organi-
zation. By examining changes in this organization under
different cellular conditions, one can potentially gain insight
into the critical transition between inactive and active func-
tional states of translocons. In this manner, we sought to dis-
tinguish between different viable models of translocon dy-
namics based on in vitro studies.
FRET between two fluorescently labeled proteins provides
a highly sensitive and specific probe of their proximity in the
low- to subnanometer range (see online supplemental mate-
rial and references therein, available at http://www.jcb.org/
cgi/content/full/jcb.200312079/DC1). To apply this meth-
odology to the endogenously expressed native translocons of
cultured cells, we decided to label individual components
using epitope-specific antibodies directly conjugated to fluo-
rescent dyes. We reasoned that despite their large size, FRET
between labeled antibodies could potentially provide useful
information regarding the proximities and organization of
their bound antigens. In the first part of this work (pre-
sented largely in online supplemental material), we com-
bined modeling and simulations to consider the feasibility of
this approach to address the anticipated questions. This 
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methodology was applied to address unanswered questions
regarding the composition and organization of translocons
at different stages of the transport cycle in cells.
Modeling and simulations of FRET between dye-conju-
gated antibodies bound to antigens in various configurations
and densities were used to estimate the resolving power of an-
tibody-mediated FRET (see online supplemental material).
From these analyses, we conclude that antibody-mediated
FRET should be capable of the following activities: (a) distin-
guishing differences in antigen proximity at the 0.5–1-nm
scale; (b) distinguishing between assembled and unassembled
states of oligomeric structures; and (c) discriminating even
small differences in relative distances that might accompany a
structural change of a multiprotein complex. These conclu-
sions suggested that, in principle, the organization of multi-
protein complexes could be assessed with antibody probes.
Thus, if endogenous translocon components could be labeled
with dye-conjugated antibodies while maintaining their over-
all organization, FRET between the dyes should provide in-
sight into translocon composition and organization.
To apply these ideas, we used variations of previous meth-
odology to label cellular proteins while preserving their rela-
tive proximities (Fig. 1 A). Intact live cells are rapidly fixed
in formaldehyde to stabilize the in situ organization of cellu-
Figure 1.  Detection of FRET between fluorescently conjugated antibodies in situ. (A) Scheme for preparation of cells for FRET analysis. 
Insets show an individual ribosome–translocon complex. Red hatches in the inset indicate formaldehyde cross-links between interacting 
proteins. The dotted lines indicate permeabilization (of the cellular membranes) or partial digestion (in the case of the ribosome). In this and 
all subsequent diagrams, the Cy3-labeled donor and Cy5-labeled acceptor antibodies are green and red, respectively. See text for complete 
details. (B) Topology maps of ER proteins analyzed in this study. The positions of peptide epitopes for antibodies are indicated with white 
boxes. (C) Western blot analysis of canine pancreatic ER microsomes with preimmune (P) or immune (I) antisera against the indicated antigens. 
(D) Indirect immunofluorescence microscopy of MDCK cells with anti-Sec61 . (E) MDCK cells were stained with Sec61 Cy5 followed by 2 Cy3. 
Shown are the fluorescence images for Cy3 (donor), Cy5 (acceptor), and merged channels (prebleach images). The Cy5 dye in the region 
indicated by the box was selectively photobleached, and the donor and acceptor channels imaged a second time (postbleach images). The 
percent change in donor intensity between the pre- and postbleach images was calculated and represented as a pseudocolor map. Note the 
 40% increase in donor fluorescence intensity within the boxed area upon acceptor photobleaching. (F) MDCK cells were stained with 2 Cy3 
bound to unlabeled anti-CNX followed by Sec61 Cy5, and the images were collected and analyzed as in E. Note the near absence of change 
in donor intensity upon acceptor photobleaching. The color scale represents the percentage of energy transfer (%E) in the pseudocolored map. 
Bars: (D–F) 5  m. 
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lar proteins with covalent cross-links between closely juxta-
posed components. Because cross-links mediated by formal-
dehyde are extremely short (
 
 
 
0.2 nm) and rapidly induced,
proteins are effectively immobilized in place without an op-
portunity to substantially change their relative proximities or
organization (Jackson, 1999). Because the preservation is co-
valent and, under the conditions applied here, effectively ir-
reversible, the samples can subsequently be subjected to
nonphysiological conditions that would have otherwise dis-
rupted labile or transient interactions.
This condition allows the fixed cells to be permeabilized
and labeled with fluorescent antibodies without changing
the organization of the translocon components or the multi-
protein complexes in which they are assembled (Fig. 1 A).
Due to the fixed nature of the antigens, the bivalent anti-
bodies cannot induce gross changes in the existing organi-
zation of their antigens. Instead, the antibodies serve to
“mark” the positions of their antigens with fluorescent
probes whose relative proximities can subsequently be as-
sessed by FRET (e.g., as modeled in online supplemental
material). Thus, the ability to assess what the state of the
translocon had been in intact cells under different condi-
tions should permit us to ask if, in cells, translocon organiza-
tion changes at different stages of the translocation cycle.
 
The sensitivity and specificity of FRET between 
dye-conjugated antibodies
 
Antibodies raised against small peptide epitopes in the cyto-
plasmic domains of the translocon components Sec61
 
 
 
,
Sec61
 
 
 
, TRAM, TRAP
 
 
 
, and SR
 
 
 
 (Fig. 1 B) were charac-
terized by immunoblotting against ER-derived microsomes
and cell lysates and indirect immunofluorescence of cultured
cells (Fig. 1, C and D; and Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200312079/DC1; unpub-
lished data). Importantly, maximal antibody binding to cer-
tain epitopes required pretreatment of the fixed and perme-
abilized cells with RNase (see online supplemental material;
Fig. S1, B and C). Although RNase may not significantly
disrupt overall ribosome structure, particularly in fixed sam-
ples, it would still digest surface-exposed loops of rRNA.
The removal of these loops, together with the fact that even
undigested ribosomes appear to be separated from translo-
cons by a substantial gap (Hanein et al., 1996; Beckmann et
al., 1997, 2001; Menetret et al., 2000; Morgan et al., 2002),
appears to be sufficient to provide antibody access to translo-
con component epitopes that are otherwise sterically oc-
cluded. Whatever the precise explanation, the unmasking of
epitopes is an important step that facilitates a uniform level
of labeling in cells regardless of whether their translocons
were actively engaged by translating ribosomes or not (Fig.
S1, E and F). Therefore, we included this RNase-mediated
unmasking step in all of the experiments.
For FRET analyses, antibodies were conjugated to the flu-
orescent dyes Cy3 or Cy5, which serve as the donor and
acceptor, respectively (see online supplemental material).
Then, we established conditions that allow the detection of
FRET between closely juxtaposed but not more widely sepa-
rated labeled antibodies. In this experiment, Cy5-conjugated
anti-Sec61
 
 
 
 (Sec61
 
 
 
Cy5
 
) bound to its antigen in MDCK
cells served as the acceptor. The donor antibody, a Cy3-con-
jugated anti–rabbit secondary antibody (2
 
 
 
Cy3
 
), was posi-
tioned in one of two places (Fig. 1, E and F, diagrams). In
Fig. 1 E, the 2
 
 
 
Cy3
 
 was bound directly to the Sec61
 
 
 
Cy5
 
 anti-
body, ensuring that all donor antibodies are adjacent to an
acceptor. Alternatively, the 2
 
 
 
Cy3
 
 antibody was bound to an
unlabeled antibody against the COOH terminus of calnexin
(CNX; Fig. 1 F), a resident ER membrane protein involved
in the posttranslational quality control of proteins (Bergeron
et al., 1994). Because in either case both the acceptor and do-
nor antibodies are bound (either directly or indirectly) to ER
antigens, their fluorescent signals colocalize at the resolution
of light microscopy (Fig. 1, E and F). In striking contrast,
the different relative positions of the donor could be readily
discriminated by assessing the FRET between the Cy3 and
Cy5 dyes (Fig. 1, E and F).
To quantitatively reveal and measure FRET, the Cy3 do-
nor fluorescence is monitored before and after the Cy5 ac-
ceptor dyes are selectively destroyed by high-intensity laser
photobleaching. Upon destruction of Cy5, the Cy3 fluores-
cence should increase by an amount corresponding to the
proportion of energy that had been transferred to Cy5 (Ken-
worthy, 2001). It should be noted that in addition to FRET,
the apparent increase in Cy3 fluorescence intensity can, un-
der some circumstances, be caused by the photoconversion
of Cy5 to a different fluorescent species that partially over-
laps with the Cy3 spectra. However, in our work, this possi-
bility was not found to be a significant source of error in the
Cy3 measurements (see online supplemental material for a
detailed discussion). Thus, the increase in Cy3 intensity seen
with Cy5 photobleaching is largely reflective of FRET be-
tween the two fluorophores.
This increase in fluorescence intensity can be qualitatively
appreciated by comparing the pre- and postbleach images of
the donor (Fig. 1 E). The extent of donor dequenching can
be measured in each 8 
 
 
 
 8 pixel region (equal to 
 
 
 
0.3 
 
 
 
m
 
2
 
)
and represented as a pseudocolored map that quantitatively
displays the percentage of energy transfer within the pho-
tobleached region. A comparison of the percentage of energy
transfer maps for Fig. 1 (E and F) reveals that the overall ef-
ficiency of FRET from the 2
 
 
 
Cy3
 
 to Sec61
 
 
 
Cy5
 
 can vary from
 
 
 
40% (Fig. 1 E) to 
 
 
 
2% (Fig. 1 F) depending on whether
or not the two antibodies are directly juxtaposed or simply
in the same subcellular compartment. Thus, sublight res-
olution differences in the relative positions of donor- and
acceptor-labeled antibodies can readily be distinguished and
quantified by FRET measured with acceptor photobleach-
ing methodology.
 
Detection of protein proximities within translocons
 
Distinguishing between different models of translocon dy-
namics requires the reliable discrimination of assembled
from disassembled multiprotein structures. To determine if
antibody-mediated FRET can provide this resolution, we as-
sessed the proximities between two resident ER membrane
proteins that should be largely assembled versus two that are
primarily disassociated at steady state. For the assembled
case, we chose Sec61
 
 
 
 and Sec61
 
 
 
, constituents of a stable
Sec61 complex whose subunits do not appear to exist in a
significant free pool (Gorlich and Rapoport, 1993). For
comparison, we probed FRET between Sec61
 
 
 
 and another 
Translocon organization in cells |
 
 Snapp et al. 1001
 
resident ER membrane protein expressed at similar levels,
CNX. Although CNX is not generally considered a core
component of the translocon, a small population of CNX
has been demonstrated to interact with a subset of pro-
teins still undergoing translocation (Molinari and Helenius,
2000). Thus, the transient nature of the interactions be-
tween CNX and nascent translocating proteins results in the
close proximity between Sec61
 
 
 
 and CNX for only a small
percentage of the total CNX, thereby representing a largely
unassembled state between these two ER proteins.
FRET, comparable to that seen for directly interacting
donor and acceptor antibodies, was observed between
Sec61
 
 
 
Cy3
 
 and Sec61
 
 
 
Cy5
 
 (Fig. 2, A and C). For the same
Sec61
 
 
 
Cy5
 
 acceptor, a CNX
 
Cy3
 
 donor antibody directed
Figure 2. Discrimination of protein proximities with low nanometer resolution. (A and B) MDCK cells were double labeled with Sec61 Cy3 
and Sec61 Cy5 (A) or CNXCy3 and Sec61 Cy5 (B) and analyzed for FRET as in Fig. 1 E. (C) Quantitative analysis of FRET between the antibody 
configurations shown in A and B. The antibody pair is indicated on the x-axis, with Sec61 Cy5 serving as the acceptor in each case. Each bar 
represents the mean   SD (n   10), with statistically significant differences (P   0.01 using t test) being observed between the two conditions. 
(D) Illustration of the relative difference in distance for antibodies on the cytoplasmic and lumenal sides of CNX. Note that moving the donor 
antibody to the other side of an  5-nm-thick membrane changes the distance to the acceptor antibody by only  1 nm in this example. (E) 
Representative energy transfer maps of FRET to Sec61 Cy5 from Cy3-labeled antibodies in three different positions. The left and middle panels 
used directly conjugated anti-CNX antibodies against the COOH and NH2 terminus, respectively. The right panel used 2 Cy3 bound to an 
unlabeled anti-CNX COOH terminus antibody. The color scale is different than in A and B to enhance visualization of differences between 
the energy transfer maps. (F) Quantitative analysis of FRET between the antibody configurations shown in E. The donor antibody is indicated 
on the x-axis, while Sec61 Cy5 served as the acceptor in each case. Each bar represents the mean   SD (n   10), with statistically significant 
differences (P   0.01 using t test) being observed between any two conditions. 
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against the cytoplasmic COOH terminus of CNX exhibited
severalfold lower FRET efficiency compared with Sec61
 
 
 
Cy3
 
(Fig. 2, B and C). In addition to the markedly lower FRET
for the CNX
 
Cy3
 
 donor, several other observations confirmed
the specificity of the Sec61
 
 
 
Cy3
 
/Sec61
 
 
 
Cy5
 
 FRET. First,
omission of the Sec61
 
 
 
Cy5
 
 resulted in no observable FRET
(i.e., no change in Sec61
 
 
 
Cy3
 
 intensity on photobleaching in
the Cy5 channel; unpublished data). Second, inclusion of a
competitor Sec61
 
 
 
 peptide resulted in reduced labeling by
Sec61
 
 
 
Cy5
 
 and correspondingly lower FRET (unpublished
data). Third, reducing the concentration of Sec61
 
 
 
Cy5
 
also resulted in lower FRET (Fig. S9, available at http://
www.jcb.org/cgi/content/full/jcb.200312079/DC1), as
would be expected for lower occupancy levels of acceptor
antigens with antibody (Fig. S4 E, available at http://
www.jcb.org/cgi/content/full/jcb.200312079/DC1). In
contrast, changing the levels of Sec61
 
 
 
Cy3
 
, although chang-
ing the overall brightness of the donor labeling, did not
affect FRET efficiency significantly (Fig. S8, available at
http://www.jcb.org/cgi/content/full/jcb.200312079/DC1),
also as predicted from theoretical considerations (Fig. S4 F).
Together, these results demonstrate that interactions be-
tween membrane proteins can be detected with antibody-
mediated FRET in situ and establish that differences in the
assembly status of abundantly expressed resident ER mem-
brane proteins can be easily discriminated.
Because some models of translocon dynamics posit small,
conformational changes rather than gross assembly and dis-
assembly, we also sought to experimentally determine if
small changes in antigen proximity at the low nanometer
scale could be reliably discriminated. Because FRET effi-
ciency for a single donor and acceptor dye pair is inversely
related to the sixth power of the distance between them (see
online supplemental material and references therein), small
increases in separation distance markedly reduce the energy
transfer. Our simulations suggested that, even for highly
flexible antibodies stochastically labeled with multiple dyes,
changes in antibody proximities corresponding to even 1 nm
should be readily detectable (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200312079/DC1). To as-
sess this experimentally, we exploited an antibody against a
different, NH
 
2
 
-terminal epitope on the lumenal domain of
CNX. Although the proximity of CNX to Sec61
 
 
 
 yields a
relatively low overall FRET signal (consistent with a separa-
tion distance of 
 
 
 
10 nm), we asked if changing the donor
antibody position from the COOH to the NH
 
2
 
 terminus on
CNX could be detected as a change in FRET. Remarkably,
this relatively subtle repositioning of the donor antibody
with respect to Sec61
 
 
 
Cy5
 
 (Fig. 2 D) decreased the FRET ef-
ficiency by nearly half of that seen with the COOH-termi-
nal antibody (Fig. 2, E and F).
Positioning the donor antibody still further away from the
COOH terminus of CNX (by using the 2
 
 
 
Cy3
 
 donor bound
to an unlabeled CNX COOH-terminal antibody) decreased
the FRET efficiency to near background levels (Fig. 2, E and
F). Based on the dimensions of the unlabeled spacer IgG, we
infer that the 2
 
 
 
Cy3
 
 donor antibody could be at most 15 nm
further from the acceptor than a directly labeled CNX 
 
Cy3
 
COOH-terminal donor. Thus, antibody-based FRET is suf-
ficiently sensitive to detect changes in distance in the size
range of individual proteins, roughly 1–15 nm. These dis-
tances are particularly relevant to the objectives of this paper
because the translocon dimensions fall within this range.
In addition, two ribosome-bound translocons are sterically
blocked from coming closer than 25 nm to each other
(Fig. S3 B, available at http://www.jcb.org/cgi/content/full/
jcb.200312079/DC1), indicating that intertranslocon FRET
should not be detectable by antibody-based FRET. Thus,
both theoretical predictions (Kubitscheck et al., 1993; Ken-
worthy and Edidin, 1998; online supplemental material) and
the donor moving experiments (Fig. 2, E and F) provided
confidence that antibody-based FRET was sensitive enough
to measure both gross and subtle changes in the organization
of components within translocons.
 
The Sec61 complex assembles into oligomers in cells
 
Purified Sec61 complex, both in solution (Hanein et al.,
1996) and when bound to a eukaryotic ribosome (Menetret
et al., 2000; Beckmann et al., 2001), is capable of forming
 
 
 
10-nm-diam toroidal structures estimated to contain at
least three copies of the Sec61 heterotrimer. However, dem-
onstrating the stoichiometry of the Sec61 complex in native
translocons has proven more difficult to address. By cryo-
EM, native channel complexes were larger, had a differently
shaped and larger central pore, and contained a substantial
lumenal protrusion not seen with Sec61p channels (Mene-
tret et al., 2000; Morgan et al., 2002). Because a ribosome
engaged in translocation tightly associates with several other
membrane proteins comparable in abundance with the
Sec61 complex (Gorlich et al., 1992; Matlack and Walter,
1995; Menetret et al., 2000), the composition and stoichi-
ometry of the components that define the native transloca-
tion channel remain uncertain.
To determine if native translocons contain Sec61 oligo-
mers, we asked whether or not FRET could be observed be-
tween two copies of a Sec61 complex subunit by labeling
cells with a mixture of Sec61
 
 
 
Cy3
 
 and Sec61
 
 
 
Cy5
 
 antibodies
at a relative ratio of 1:8. If homooligomers exist, each copy
of the donor-labeled Sec61
 
 
 
 is likely to be adjacent (within
10–15 nm) to a copy of the far more numerous acceptor-
labeled antibodies. In contrast, a single Sec61 complex per
translocon should result in an inter-Sec61
 
 
 
 distance, even
within polysomes, of at least 25 nm, a distance beyond
which little or no FRET is observed. Thus, the 
 
 
 
17%
FRET efficiency for Sec61
 
 
 
Cy3
 
/Sec61
 
 
 
Cy5
 
 pair (Fig. 3 A)
provides direct evidence that native translocons in cells are
composed of at least two Sec61 heterotrimers.
Direct comparisons of the FRET efficiency for Sec61
 
 
 
Cy3/
Sec61 Cy5 with that observed between Sec61  and
Sec61 Cy5 provided additional support for this conclusion.
Here, directly conjugated Sec61  donor antibodies dis-
played a FRET efficiency to Sec61 Cy5 higher than that seen
with Sec61 Cy3/Sec61 Cy5 ( 30% vs.  17%; Fig. 3, A and
B). In contrast, spacing the donor antibody using an unla-
beled Sec61  antibody showed a lower FRET efficiency
( 7%; Fig. 3 C). Because the spacer antibody dimensions
are at most 15 nm and the Sec61 Cy3/Sec61 Cy5 FRET effi-
ciency is bracketed between the FRET values for directly
conjugated Sec61  and that seen with the spacer antibody,
we conclude that one copy of Sec61  must be within  15Translocon organization in cells | Snapp et al. 1003
nm of another copy. In other experiments, Sec61 Cy3/
Sec61 Cy5 also displayed comparably high FRET (see the
following section; Table I), providing additional evidence
for oligomeric Sec61 heterotrimers. These values are consis-
tent with the estimated dimensions of native translocons
(Menetret et al., 2000) and theoretical simulations of anti-
bodies separated by roughly 8–10 nm (see online supple-
mental material). Together, these results strongly argue
that the observed FRET for Sec61 Cy3/Sec61 Cy5 and
Sec61 Cy3/Sec61 Cy5 is detecting oligomerized Sec61 com-
plexes within native translocons. Thus, the data in Figs. 2
and 3 not only demonstrate that protein–protein interac-
tions within the translocon can be detected with high resolu-
tion in cells but that the proximities of copies of a subunit of
the Sec61 complex can be used to directly probe its oligo-
meric status.
Core translocon organization during the transport cycle
These results permitted us to simply and directly address a
long-standing unresolved issue regarding the dynamics of
the translocon: what happens to the translocation channel
when it is not actively engaged in substrate transport? To re-
solve this question, we first established conditions to com-
plete translocation by terminating protein synthesis ei-
ther  prematurely with puromycin, which releases nascent
polypeptides from the ribosome, or naturally with pactamy-
cin, an inhibitor of translational initiation. Pulse labeling of
cells treated with 1 mM puromycin demonstrated that
within 5 min, the synthesis of radiolabeled proteins longer
than  50–70 residues was effectively inhibited due to pre-
mature termination. Pactamycin also inhibits new protein
synthesis within 5 min, but as expected for an inhibitor of
initiation, an additional 10 min was required to complete
translation of already engaged mRNAs (Fig. 4 A). Impor-
tantly,  95% of the translocons were bound to ribosomes
in a salt-resistant manner, whereas  5% remained bound if
cells were pretreated with puromycin (Fig. 4 B). Because the
high salt containing solubilization conditions used in the
fractionation studies maintain ribosome–translocon interac-
tions only in the presence of a nascent chain (Gorlich et al.,
1992; Jungnickel and Rapoport, 1995), this result demon-
strates that the vast majority of translocons are engaged in
translocation in untreated cells, whereas they are nearly
quantitatively vacated upon treatment with puromycin (or
pactamycin; unpublished data).
Next, we investigated whether or not the oligomeric state
of the Sec61 complex in cells was maintained or lost upon
the completion of substrate translocation by measuring
FRET between all combinations of Sec61  and Sec61  un-
der the two extremes of translocon usage and quiescence.
Ten independent FRET measurements were performed on
separate cells that were either treated with puromycin or
pactamycin or left untreated (Fig. 4, C–F). For each anti-
body pair, the FRET efficiencies were comparable for ac-
tively engaged versus nontranslocating translocons. Impor-
tantly, our observation that in untreated cells, the majority
of Sec61  or Sec61  labeling is dependent on RNase diges-
tion (Fig. S1) suggests that we are indeed visualizing and
making measurements on engaged translocons. Thus, the
finding of comparable FRET values after puromycin and
pactamycin treatments suggests that the oligomeric structure
of active translocons is maintained even after completion of
substrate translocation. Therefore, we conclude that the core
of a native translocation channel does not disassemble into
its individual components upon completion of substrate
transport in vivo.
What then distinguishes an engaged from a quiescent
translocon? As discussed in the Introduction, the translocon
could be structurally identical in both cases (Menetret et al.,
2000) or could undergo a conformational change (Hamman
Figure 3. Detection and characterization of Sec61 complex oligomerization in situ. (A–C) Direct comparisons of FRET efficiencies to 
Sec61 Cy5 from three different donor antibodies: Sec61 Cy3 (at a ratio of 1:8; A), Sec61 Cy3 (B), and 2 Cy3 bound to unlabeled anti-Sec61  (C). 
(D) Quantitation (mean   SD; n   10) of the comparisons from A–C are shown.
Table I. Changes in Sec61 complex configuration during the 
translocation cycle
Donor Acceptor Untreated Puromycin Pactamycin
Sec61  Sec61  38.3   4.4 33.6   7.2
a 35.5   5.1
a
Sec61  Sec61  26.4   2.1 27.9   2.7
a 28.0   2.1
a
Sec61  Sec61  41.8   3.1 46.1   2.8
a 46.8   3.0
a
Sec61  Sec61  21.4   3.6 24.8   6.1
a 23.9   2.5
a
FRET efficiencies (mean   SD; n   40) for the indicated donor–acceptor
antibody pairs were measured on cells that were either left untreated
or pre-treated for 15 min with 1 mM puromycin or 0.2  M pactamycin.
Each value is the mean of measurements collected from four separate
experiments performed on multiple days.
aTreatment is significant (P   0.01) compared with untreated cells using t test.1004 The Journal of Cell Biology | Volume 164, Number 7, 2004
et al., 1997; Beckmann et al., 2001). Because antibody-medi-
ated FRET, in principle, can discriminate even small differ-
ences in the distances separating antigens, we used this
method to determine if a change in organization distin-
guishes translocating from quiescent translocons in cells.
Careful examination of the data in Fig. 4 hinted at small, sys-
tematic differences in FRET efficiencies for some of the anti-
body pairs upon completion of translocation. This possibility
was verified with more thorough analyses compiling 40 in-
dependent FRET measurements of engaged versus inactive
translocons for each antibody pair. Statistical comparisons of
untreated versus treated cells revealed small but significant
differences for each of the donor/acceptor pairs (Table I).
Several observations suggest that the changes in FRET are
specific and reflect the changes in organization that dis-
tinguish engaged and inactive translocons. First, the level
of antibody labeling was not different for either Sec61 
or Sec61  in untreated versus puromycin or pactamycin
treated cells (Fig. S1, E and F). This finding argues against
changes in FRET due simply to differential labeling or anti-
body accessibility. Second, two qualitatively different meth-
ods of vacating the translocon shift the FRET value in the
same direction (either up or down) for each of the four anti-
body pairs tested. In addition, the lack of statistically signifi-
cant differences between puromycin and pactamycin treat-
ments for any antibody pair argues that both methods of
completing translocation are equivalent from the standpoint
of the structural state achieved by the Sec61 components.
Third, the FRET values for the reciprocal antibody pairs
Sec61 Cy3/Sec61 Cy5 and Sec61 Cy3/Sec61 Cy5 similarly in-
crease upon completion of translocation, as would be ex-
pected for simply switching the donor and acceptor fluoro-
phores on the same antibodies. The difference in the
absolute FRET values observed for Sec61 Cy3/Sec61 Cy5
versus Sec61 Cy3/Sec61 Cy5 is likely due to small differences
in dyes per antibody for the different antibody preparations
and the efficiency of antigen occupancy for the two antibod-
ies (Fig. S4). Fourth, the increase in FRET for Sec61 Cy3/
Sec61 Cy5 with a concomitant decrease for Sec61 Cy3/
Sec61 Cy5 argues against additional or fewer Sec61 hetero-
trimers being assembled into oligomers. Instead, this re-
sult, coupled with the increased FRET for both Sec61 Cy3/
Sec61 Cy5 and Sec61 Cy3/Sec61 Cy5, is most consistent with
the preexisting oligomerized Sec61 complexes undergoing a
small but detectable change in configuration.
TRAM, TRAP, and SR associations with translocons
If the core translocon remains intact throughout the translo-
cation cycle, what happens to proteins that do not necessarily
stably associate with the translocon, and yet are essential for
discrete steps of translocation? To address this question, we
focused on three proteins, SR , TRAM, and TRAP , each
of which are thought to be needed during early stages of
translocation. Whether or not they are needed at stages after
the initiation of substrate translocation remains unclear. Sim-
ilarly, it is not known if they are recruited to translocons tran-
Figure 4. Translocon component organization during the translocation cycle. (A) MDCK cells were either left untreated (unt.) or pretreated 
with 1 mM puromycin (puro.) or 0.2  M pactamycin (pact.) for the indicated times before pulse labeling for 10 min with [
35S]methionine in 
the presence of the drug. Shown are autoradiographs of total cell lysates. Coomassie blue staining of the gel revealed equal amounts of total 
protein in each lane (not depicted). (B) Untreated or puromycin-treated (1 mM for 15 min) cells were lysed in detergent (0.8% deoxyBigCHAP) 
and high salt (500 mM KAc) and analyzed by sucrose density gradient sedimentation for Sec61 complex association with ribosomes. Shown 
are immunoblots for Sec61  and CNX of individual fractions of the gradient. The position of ribosomes on the gradient is indicated. (C–F) 
Untreated, puromycin-treated, and pactamycin-treated cells were analyzed for FRET between Sec61 Cy3/Sec61 Cy5, Sec61 Cy3/Sec61 Cy5, 
Sec61 Cy3/Sec61 Cy5, and Sec61 Cy3/Sec61 Cy5 as indicated. Each point on the graph represents a single FRET measurement performed as in 
Fig. 1 D. n   10 for each condition tested.Translocon organization in cells | Snapp et al. 1005
siently in a use-dependent manner (e.g., as CNX is thought
to be) or if they instead are more stably part of the translocon
structure (e.g., as are subunits of the Sec61 complex).
We reasoned that these possibilities should be discernible
with FRET in two ways. First, FRET between each compo-
nent and the Sec61 complex under conditions of ongoing
translocation may reveal whether, at steady-state, a signifi-
cant proportion of the proteins are associated with the core
translocon or not. Second, if their associations are use- or
substrate-dependent, relieving translocons of their substrates
with puromycin or pactamycin should result in a loss of
FRET signal. Analysis of FRET between SR , TRAM, and
TRAP  donor antibodies with Sec61 Cy5, and to a lesser ex-
tent Sec61 Cy5, revealed FRET efficiencies higher than that
seen with a CNX donor (Table II; compare for example with
Fig. 2, B–D). Instead, many of the FRET efficiencies were
more comparable to that seen between subunits of the Sec61
complex (Table I). It should be noted that the systematically
lower FRET values seen with the Sec61  acceptor (Table II)
appear to be due to small differences in dyes per IgG for the
different antibody preparations and do not necessarily indi-
cate a higher distance separating the antigens. That notwith-
standing, the data suggest that at steady state, at least some
proportion of SR , TRAM, and TRAP  is likely to be part
of Sec61-containing translocons.
However, the absolute amounts of SR, TRAM, and
TRAP that are incorporated into translocons are difficult to
judge based on the FRET results alone. For the TRAP com-
plex, previous biochemical analyses have demonstrated that
the vast majority is tightly associated with membrane-bound
ribosomes (Gorlich and Rapoport, 1993; Matlack and Wal-
ter, 1995), which is consistent with a high degree of incor-
poration into translocons. Similar observations for TRAM
and SR are lacking because under the conditions analyzed
any potential association that might have existed in intact
membranes was not maintained upon detergent solubiliza-
tion. However, our observation that SR  and TRAM gave
quantitatively similar FRET values as TRAP  for both the
Sec61  and Sec61  acceptors may suggest that, in cells, a
comparably high percentage of all three components is in-
corporated into active translocons.
Upon puromycin or pactamycin treatment of cells, many
FRET pairs in Table II underwent a small but statistically
significant change, with no FRET pair decreasing to  70%
of that seen in untreated cells. In some cases, the FRET effi-
ciencies even increased slightly. In every case, the FRET val-
ues changed (either increased or decreased) in the same di-
rection for both puromycin- and pactamycin-treated cells,
although not all achieved statistical significance presumably
due to an insufficiently large sample size. That notwith-
standing, the relative lack of change in FRET among the
components analyzed in Table II suggests that a significant
degree of disassembly does not occur on completion of sub-
strate translocation. If the majority of these components is
incorporated into translocons in untreated cells (as is argued
in the previous two paragraphs), these results would suggest
that the close proximity of most SR , TRAM, and TRAP 
to the Sec61 complex is an inherent feature of translocon
structure and not a consequence of a translocating substrate.
Discussion
In this work, we have used FRET between directly labeled
antibodies to address several basic issues of protein translocon
organization and composition in mammalian cells. These ex-
periments have allowed us to draw three principal conclu-
sions regarding translocons in vivo that had either not been
addressed or had yielded conflicting results with previous ap-
proaches. First, in cells fixed at steady state, while growing
under metabolically active conditions, the vast majority of
Sec61 complexes are assembled into oligomeric structures.
Second, these structures, while remaining oligomeric, un-
dergo a change in configuration between rounds of protein
translocation. Third, SR, TRAM, and TRAP do not appear
to significantly change their associations with the Sec61 com-
plex after completion of substrate translocation. These find-
ings have several implications for translocation, each of which
is briefly discussed in the following paragraphs.
The decisive step in cotranslational protein translocation
is the achievement of a stable ribosome–translocon complex
in which the nascent chain has access to the ER lumen, is
shielded from the cytosol, and has committed to forward
translocation (Crowley et al., 1994; Jungnickel and Rapo-
port, 1995; Voigt et al., 1996; Fons et al., 2003). Because
completion of protein synthesis or initiation of nascent
chain folding before achieving this committed stage results
in a cytoplasmically localized substrate (Perara et al., 1986),
the precommitment steps in translocation face severe tempo-
ral constraints. Additional constraints in vivo include a
crowded cellular environment (Luby-Phelps et al., 1986),
the large size and low diffusional mobility of ribosome–
nascent chain complexes (Rolls et al., 2002), and a poten-
tially limited availability of unengaged components in meta-
bolically active cells (Fig. 4 B). How these constraints are
efficiently overcome despite requiring the coordinated ac-
tions of up to five components (SRP, SR, TRAM, and the
Sec61 and TRAP complexes) has been unclear.
The targeting of nascent chains to the ER includes a tran-
sient SRP-mediated slowdown in translation, which pro-
vides one mechanism for overcoming the temporal con-
straints on initiating translocation (Walter and Johnson,
1994). However, later steps, including transfer to the trans-
locon, insertion of nascent chains into the channel, and ini-
tiation of translocation, do not appear to involve such trans-
lational pauses. We now provide evidence suggesting that
these posttargeting steps may be spatially coupled by preas-
Table II. Maintenance of translocon component interactions during 
the translocation cycle
Donor Acceptor Untreated Puromycin Pactamycin
SR  Sec61  34.1   5.2 31.6   7.3 32.2   4.2
SR  Sec61  16.0   2.2 17.2   3.3 18.8   2.8
a
TRAP  Sec61  18.4   6.4 13.6   5.6
a 15.2   4.9
TRAP  Sec61  13.6   3.5 11.1   3.1
a 11.8   2.7
TRAM Sec61  17.6   4.2 19.8   2.9
a 19.7   4.4
TRAM Sec61  12.8   2.7 11.9   2.0 10.4   1.1
a
FRET efficiencies for the indicated donor–acceptor antibody pairs were
measured and tabulated as in Table I.
aTreatment is significant (P   0.01) compared with untreated cells using t test.1006 The Journal of Cell Biology | Volume 164, Number 7, 2004
sembled translocon structures that are present even before
their engagement by a substrate. We suggest that this per-
mits sequential interactions to occur in rapid succession due
to the close and constant proximity of the necessary compo-
nents. Thus, an initial temporal checkpoint (SRP-mediated
pausing), together with spatial coupling of the remaining
steps, can ensure high fidelity and efficiency of translocation
despite the various obstacles posed in vivo.
Currently, it is not known how the various translocon
components remain associated in vivo given that biochemi-
cal studies have yet to reveal stable associations between
them. One possibility is that the conditions required to sol-
ubilize the translocon components disrupt interactions that
are more stable in the context of an intact lipid bilayer. A
more intriguing possibility is that a nontranslating ribo-
some, which can bind stably to the Sec61 complex under
physiologic salt conditions (Kalies et al., 1994), provides a
platform for maintaining translocon complexes in an as-
sembled state. For example, it was recently suggested that
SR may be close to the translocon (Wittke et al., 2002) and
may interact directly with the ribosome (Mandon et al.,
2003), which may remain translocon-bound even in the ab-
sence of ongoing translocation (Potter and Nicchitta, 2002;
Nikonov et al., 2002). If ribosomes indeed do not detach
from translocons after substrate translocation, then the lack
of significant disassembly of translocon components be-
tween rounds of transport (Tables I and II) may be due to
an organizing function imparted by the bound ribosome.
Thus, the more complete disassembly observed on ER solu-
bilization in vitro requiring high salt-mediated removal of
ribosomes from translocons may not normally occur be-
tween rounds of transport in vivo. Further studies will be
needed to determine the molecular basis of the maintenance
of close proximities among the translocon components re-
vealed in this work.
Materials and methods
Antibodies
Antipeptide rabbit antisera against Sec61 , SR , and TRAP  have been
described previously (Fons et al., 2003). Antipeptide antiserum against the
COOH termini of canine Sec61  and TRAM were gifts from K. Kellaris and
R. Gilmore (University of Massachusetts School of Medicine, Worcester,
MA) and K. Matlack and P. Walter (University of California, San Francisco,
San Francisco, CA). Rabbit antisera against residues 575–593 (in the
COOH-terminal tail of canine CNX) and against residues 50–68 (near the
NH2 terminus of canine CNX) were obtained from StressGen Biotechnolo-
gies. The IgG fraction from each of these antibodies was purified by pro-
tein A chromatography and labeled using Cy3 or Cy5 monoreactive dye
packs (Amersham Biosciences) with slight modifications to the manufac-
turer’s instructions. In brief, 3 mg IgG (in 0.9 ml PBS) was mixed with 0.1
ml 1 M NaHCO3 (pH 9.0) and added to one vial of the dye pack. After 20
min with occasional mixing, the reaction was terminated by separation of
the IgG from unreacted dye by Sephadex G-25 chromatography in PBS.
This procedure results in the reliable conjugation of  3.5–4.5 dyes/IgG.
Conjugated antibodies falling outside this range were not used. Cy3-conju-
gated anti–rabbit IgG was obtained from Jackson ImmunoResearch Labo-
ratories and contained an average of  2.5 dyes/IgG. HRP-conjugated sec-
ondary antibodies were obtained from Amersham Biosciences.
Cell culture and sample preparation
MDCK cells were grown in DME containing 10% FBS and glutamine. For
imaging, cells were grown in fibronectin-coated 8-chambered Lab-Tek
glass coverslips (Nunc) to 40–70% confluence. Translational inhibition (1
mM puromycin; Calbiochem) or 0.2 mM pactamycin (a gift from E. Stein-
brecher, Pharmacia Corp., Peapack, NJ) was performed for 15 min at
37 C before fixation. Cells were fixed with 3.7% formaldehyde in PBS for
15 min at RT, washed with PSS (PBS with 10% FBS, 0.1% saponin), and
blocked 1 h at RT with PSS containing 50  g/ml RNase A. Three different
labeling protocols were used depending on the configuration of antibod-
ies desired. In experiments where two directly labeled primary antibodies
were used, the Cy3- and Cy5-conjugated antibodies were premixed be-
fore incubating with cells. In experiments where the 2 Cy3 donor antibody
was bound directly to the acceptor antibody, labeling was performed se-
quentially. After binding the Cy5-labeled antibody as aforementioned, the
cells were washed before binding the Cy3-labeled secondary antibody. In
experiments using an unlabeled “spacer” antibody to which the 2 Cy3 do-
nor antibody was bound, labeling was performed in multiple steps. First,
the unlabeled primary antibody was bound, after which the cells were
washed, before binding 2 Cy3. After washing, the samples were fixed with
3.7% formaldehyde. Any remaining antigen binding sites on the second-
ary antibody were blocked with PBS containing 5% rabbit serum and
0.1% saponin, and subsequently incubated with the Cy5-conjugated anti-
bodies. After completion of each of the labeling protocols, samples were
washed and the cells were either viewed immediately or postfixed in
3.7% formaldehyde (which had no effect on the FRET observed) before
rinsing into PSS for imaging.
Microscopy and image analysis
Images were acquired with a confocal microscope (model LSM-510; Carl
Zeiss MicroImaging, Inc.) using a 1.4 NA 63  oil objective using 543 and
633 nm HeNe laser lines with 560–615 and 650 filters with open pinholes.
Complete photobleaching of Cy5 was accomplished by 125 iterative scans
with 5 mW illumination at zoom 4. Images were collected sequentially in
the Cy3 and Cy5 channels immediately before and after photobleaching a
region. FRET quantitation and generation of the energy transfer map were
automated using custom macros (available upon request) written for NIH
Image 1.62. Two experiments confirmed the specificity of donor de-
quenching. Acceptor-only labeled samples ensured no bleed-through into
the donor channel. A donor-only labeled sample was shown to not change
in intensity upon bleaching in the acceptor channel under the bleach con-
ditions used.
Biochemical analyses
Lysates from MDCK cells for immunoblots (Fig. S1 A) were prepared in
100 mM Tris, pH 8, 500 mM KAc, 5 mM MgCl2, and 1% Triton X-100. Af-
ter removing any insoluble material (10 min at maximum speed in a micro-
centrifuge), the proteins were precipitated with 15% TCA, washed in ace-
tone, and analyzed by SDS-PAGE and immunoblotting. Canine pancreatic
rough microsomal membranes were solubilized directly in SDS-PAGE
sample buffer and analyzed by immunoblotting. For metabolic labeling,
cells growing in 12-well dishes at  70% confluence were treated with
translational inhibitors in methionine-free media for between 5–30 min be-
fore the addition of [
35S]methionine/cysteine Translabel (ICN Biochemi-
cals) to 100  Ci/ml. After 10 min of labeling at 37 C, cells were rinsed
once in PBS, solubilized in 100  l 1% SDS/0.1 M Tris (pH 8.0), and heated
in a boiling water bath, and a 5- l aliquot was analyzed by SDS-PAGE and
autoradiography. For sucrose gradient analysis, a 6-well dish containing
cells at  70% confluence was transferred to ice, rinsed in ice-cold PBS,
and scraped into 500  l of ice-cold 50 mM Hepes, pH 7.4, 500 mM KAc,
5 mM MgAc2, 0.8% deoxyBigCHAP (Calbiochem), and 1 mM DTT. Cells
were solubilized by repeated passage through a small-bore pipette tip and
sedimented at 10,000 g for 10 min in a refrigerated microcentrifuge, and
200  l of the supernatant was applied to a 2-ml 10–50% (wt/vol) sucrose
gradient containing the solubilization buffer. After centrifugation for 1 h at
55,000 rpm in a TLS-55 rotor (Beckman Coulter), 11 fractions were re-
moved and the proteins precipitated with TCA and analyzed by immuno-
blotting. Fractions containing ribosomes were identified in separate gradi-
ents by monitoring absorbance at 260 nm or Coomassie blue staining of
the fractions.
Miscellaneous
SDS-PAGE was performed on 12% Tris-tricine gels. Immunoblotting was
performed after transfer to nitrocellulose and development was with Super-
signal chemiluminescence reagents (Pierce Chemical Co.). Figures were
assembled using Photoshop and Illustrator software (Adobe).
Online supplemental material
Nine supplemental figures, accompanying text, and figure legends are
available online. These provide additional experimental characterization
of the FRET methodology (Figs. S1 and S7–S9) and theoretical analyses of
ensembles of fluorophores conjugated to antibodies (Figs. S2–S6). OnlineTranslocon organization in cells | Snapp et al. 1007
supplemental material is available at http://www.jcb.org/cgi/content/full/
jcb.200312079/DC1.
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